SEC Form 4 · accession 0001209191-15-044078
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurent Fischer
Officer — Chief Executive Officer · Director
Period of report
May 15, 2015
Accepted (ET)
May 18, 2015 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $14.00 | May 15, 2015 | A | 105,000 | A | — | May 14, 2025 | Common Stock | 105,000 | 105,000 | D |
Explanation of responses
- F126,250 shares subject to the stock option shall vest on the first anniversary of the date of grant. The remaining shares vest ratably in equal monthly installments over a three (3) year period following the one (1) year anniversary of the date of grant.